# MAGEB3

## Overview
MAGEB3 is a gene that encodes the protein MAGE family member B3, which is part of the melanoma-associated antigen (MAGE) protein family. This family is characterized by its role in cancer/testis antigens, which are typically expressed in various tumors and the testis but not in normal tissues. MAGEB3 is involved in complex protein-protein interactions, particularly with other MAGE family members, and plays a significant role in germ cell differentiation and maturation. The protein is categorized as a cancer/testis antigen and is implicated in oncogenic processes, as its expression is correlated with tumor characteristics such as size, lymph node involvement, and cancer stage in colorectal cancer (Chung2010Differential). Additionally, MAGEB3 is overexpressed in hepatocellular carcinoma due to hypomethylation, which is associated with poor prognosis and advanced tumor features (Lubecka2018Locispecific). These attributes make MAGEB3 a potential target for cancer immunotherapy and a biomarker for cancer progression.

## Clinical Significance
MAGEB3, a member of the MAGE gene family, is implicated in various cancers due to its altered expression levels. In colorectal cancer (CRC), MAGEB3 is significantly overexpressed and correlates with clinical characteristics such as tumor size, lymph node status, and UICC stage. It is notably overexpressed in cases with negative lymph node metastasis and early UICC stages (I and II), suggesting its potential role in tumor progression and staging (Chung2010Differential).

In hepatocellular carcinoma (HCC), MAGEB3 is overexpressed due to hypomethylation, which is linked to advanced tumor grade, metastasis, invasion, and poor prognosis. This suggests a potential oncogenic role for MAGEB3 in HCC (Lubecka2018Locispecific). The gene's expression is also associated with immune response activation, indicating its involvement in cancer progression through immune pathways (Lubecka2018Locispecific).

In breast cancer, high mRNA expression levels of MAGEB3 are associated with a better prognosis, although the specific clinical significance of mutations or interaction changes is not detailed (Jia2019Prognostic). These findings highlight the potential of MAGEB3 as a biomarker and target for cancer immunotherapy.

## Interactions
MAGEB3, a member of the MAGE protein family, is involved in a network of protein-protein interactions that are significant in the context of cancer/testis antigens. MAGEB3 interacts with other MAGE family members, such as MAGEA1, MAGEB4, and MAGEB6. Specifically, MAGEA1 has been shown to interact with MAGEB3, MAGEB4, and MAGEB6, suggesting a complex interplay among these proteins that may be crucial for understanding germ cell differentiation and maturation (Vandenbrouck2020The).

In the context of cancer, MAGEB3 expression has been statistically correlated with tumor size, lymph node involvement, and UICC stage in colorectal cancer, indicating its potential role in cancer progression (Chung2010Differential). Although specific protein interactions in cancer are not detailed, the overexpression of MAGEB3 in tumors suggests it may participate in oncogenic pathways.

While the precise molecular interactions of MAGEB3 remain to be fully elucidated, its involvement in protein networks and correlation with cancer characteristics highlight its potential as a target for therapeutic interventions. Further research is needed to clarify the specific interactions and mechanisms by which MAGEB3 influences cellular processes.


## References


[1. (Vandenbrouck2020The) Yves Vandenbrouck, Charles Pineau, and Lydie Lane. The functionally unannotated proteome of human male tissues: a shared resource to uncover new protein functions associated with reproductive biology. Journal of Proteome Research, 19(12):4782–4794, October 2020. URL: http://dx.doi.org/10.1021/acs.jproteome.0c00516, doi:10.1021/acs.jproteome.0c00516. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jproteome.0c00516)

[2. (Jia2019Prognostic) Binghan Jia, Xiaoling Zhao, Yao Wang, Jinlong Wang, Yingying Wang, and Yuemei Yang. Prognostic roles of mage family�members in breast cancer based on km‑plotter data. Oncology Letters, August 2019. URL: http://dx.doi.org/10.3892/ol.2019.10722, doi:10.3892/ol.2019.10722. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2019.10722)

[3. (Lubecka2018Locispecific) Katarzyna Lubecka, Kirsty Flower, Megan Beetch, Jay Qiu, Lucinda Kurzava, Hannah Buvala, Adam Ruhayel, Samer Gawrieh, Suthat Liangpunsakul, Tracy Gonzalez, George McCabe, Naga Chalasani, James M Flanagan, and Barbara Stefanska. Loci-specific differences in blood dna methylation in hbv-negative populations at risk for hepatocellular carcinoma development. Epigenetics, 13(6):605–626, June 2018. URL: http://dx.doi.org/10.1080/15592294.2018.1481706, doi:10.1080/15592294.2018.1481706. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15592294.2018.1481706)

[4. (Chung2010Differential) Fu‐Yen Chung, Tian‐Lu Cheng, Hui‐Jen Chang, Hua‐Hsien Chiu, Ming‐Yii Huang, Ming‐Sung Chang, Chung‐Chi Chen, Ming‐Je Yang, Jaw‐Yuan Wang, and Shiu‐Ru Lin. Differential gene expression profile of mage family in taiwanese patients with colorectal cancer. Journal of Surgical Oncology, 102(2):148–153, July 2010. URL: http://dx.doi.org/10.1002/jso.21580, doi:10.1002/jso.21580. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jso.21580)